Latest Breaking News On - European league against - Page 1 : comparemela.com

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystem involvement. It is multifactorial and involves epigenetic, genetic, ecological, and environmental factors. Primarily it leads to activation of both innate and adaptive immunity, which consequently leads to autoreactive B cell activation by T cells and leads to immune complexes deposition in tissues leading to an autoimmune cascade that may be limited to the single organ or can cause a widespread systemic involvement. SLE is heterogeneous in presentation, with a broad spectrum of clinical manifestations ranging from clinically mild self-resolving symptoms to severe life-threatening organ involvement. Clinical and serological heterogeneity are critical features in SLE, posing a significant challenge in its diagnosis. Antinuclear antibodies (ANA) are the telltale serological marker in more than 95% of SLE patients. The improved set of European Alliance of Associations for Rheumatology (EULAR) classif

United statesAmerican college of rheumatology damage indexSystemic lupus international collaborating centersBritish isles lupus assessment groupAmerican college of rheumatologySystemic lupus international collaborating clinicsNorth americaAfrican americanC terminal srcApoptotic cellsPeripheral nervousCutaneous lupus erythematosusLupus erythematosusAmerican collegeEuropean league againstSystemic lupus erythematosus disease activity